SERPING1 Antibody - #DF4299
Product: | SERPING1 Antibody |
Catalog: | DF4299 |
Description: | Rabbit polyclonal antibody to SERPING1 |
Application: | WB IHC IF/ICC |
Reactivity: | Human, Mouse |
Prediction: | Pig |
Mol.Wt.: | 55 KD; 55kD(Calculated). |
Uniprot: | P05155 |
RRID: | AB_2836650 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF4299, RRID:AB_2836650.
Fold/Unfold
C1 esterase inhibitor; C1 Inh; C1 inhibiting factor; C1 inhibitor; C1-inhibiting factor; C1IN; C1Inh; C1NH; complement component 1 inhibitor; esterase inhibitor; HAE1; HAE2; IC1_HUMAN; Plasma protease C1 inhibitor; Serine (or cysteine) proteinase inhibitor clade G member 1; serine/cysteine proteinase inhibitor clade G member 1; Serpin G1; serpin peptidase inhibitor, clade G (C1 inhibitor), member 1; SERPING1;
Immunogens
- P05155 IC1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MASRLTLLTLLLLLLAGDRASSNPNATSSSSQDPESLQDRGEGKVATTVISKMLFVEPILEVSSLPTTNSTTNSATKITANTTDEPTTQPTTEPTTQPTIQPTQPTTQLPTDSPTQPTTGSFCPGPVTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVARTLLVFEVQQPFLFVLWDQQHKFPVFMGRVYDPRA
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P05155 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
R4 | Methylation | Uniprot | |
N25 | N-Glycosylation | Uniprot | |
T47 | O-Glycosylation | Uniprot | |
T48 | O-Glycosylation | Uniprot | |
S64 | O-Glycosylation | Uniprot | |
N69 | N-Glycosylation | Uniprot | |
T71 | O-Glycosylation | Uniprot | |
N81 | N-Glycosylation | Uniprot | |
T83 | O-Glycosylation | Uniprot | |
T88 | O-Glycosylation | Uniprot | |
T92 | O-Glycosylation | Uniprot | |
T96 | O-Glycosylation | Uniprot | |
N238 | N-Glycosylation | Uniprot | |
N253 | N-Glycosylation | Uniprot | |
Y294 | Phosphorylation | Uniprot | |
S296 | Phosphorylation | Uniprot | |
K316 | Acetylation | Uniprot | |
K321 | Acetylation | Uniprot | |
N352 | N-Glycosylation | Uniprot | |
S375 | Phosphorylation | Uniprot | |
S460 | Phosphorylation | Uniprot |
Research Backgrounds
Activation of the C1 complex is under control of the C1-inhibitor. It forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases. May play a potentially crucial role in regulating important physiological pathways including complement activation, blood coagulation, fibrinolysis and the generation of kinins. Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein.
Highly glycosylated (49%) with N- and O-glycosylation. O-glycosylated with core 1 or possibly core 8 glycans. N-glycan heterogeneity at Asn-25: Hex5HexNAc4 (minor), dHex1Hex5HexNAc4 (minor), Hex6HexNAc5 (major) and dHex1Hex6HexNAc5 (minor).
Can be proteolytically cleaved by E.coli stcE.
Secreted.
Binds to E.coli stcE which allows localization of SERPING1 to cell membranes thus protecting the bacteria against complement-mediated lysis. Interacts with MASP1.
Belongs to the serpin family.
Research Fields
· Human Diseases > Infectious diseases: Bacterial > Pertussis.
· Organismal Systems > Immune system > Complement and coagulation cascades. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.